Advertisement
Screener

BRIACELL THERAPEUTICS CORP. (BCTX) Current Assets

2.8 / 5 stars · 68/120 Roast Me

BRIACELL THERAPEUTICS CORP. Current Assets

BRIACELL THERAPEUTICS CORP. (BCTX) had Current Assets of $46.23 million as of 2022-04-30, per its 6-K filed 2022-06-13.

Discontinued › Notes

ifrs-full:CurrentAssets · last filed 2022-06-13

  • 2020-07-31: Current Assets 321.21K CAD.
  • 2019-08-01: Current Assets 207.04K CAD.

CAD

Period endCurrent Assets
2020-07-31321.21K CAD
40-F/A · filed 2021-11-16
2019-08-01207.04K CAD
40-F/A · filed 2021-11-16

USD

Period endCurrent Assets
2022-04-30$46.23M
6-K · filed 2022-06-13
2022-01-31$48.32M
6-K · filed 2022-03-15
2021-07-31$57.80M
6-K · filed 2022-06-13
2020-07-31$261.46K
40-F/A · filed 2021-11-16
2019-08-01$168.53K
40-F/A · filed 2021-11-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
PMGC Holdings Inc. (ELAB)United States$0.037B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Celularity Inc (CELU)United States$0.038B-0.34
CervoMed Inc. (CRVO)United States$0.038B-1.39
Edesa Biotech, Inc. (EDSA)Canada$0.039B
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98